Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002570 · ClinicalTrials.gov registry record · Phase 3

Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease

A Phase 3 study, sponsored by NCIC Clinical Trials Group.

Completed
Registry status
Phase 3
Development phase
67
Enrollment target

NCT00002570 is a Phase 3 study that has completed, run by NCIC Clinical Trials Group. The registered enrollment target is 67 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002570, a Phase 3 study, has completed, sponsored by NCIC Clinical Trials Group.

COMPLETED
Registry status
Phase 3
Development phase
67 participants
Enrollment target

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which treatment regimen is more effective for colorectal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of immediate with delayed fluorouracil plus leucovorin in treating patients with advanced colorectal cancer without signs or symptoms of disease.

Interventions

  • DRUG fluorouracil
  • DRUG leucovorin calcium

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 1994-07-15
Est. Completion 2009-02-10
Phase Phase 3

Sponsor

NCIC Clinical Trials Group

21 total trials

What the Registry Record Tells You About NCT00002570

The ClinicalTrials.gov registry entry for NCT00002570 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NCIC Clinical Trials Group, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which fluorouracil is the first listed.

NCT00002570 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00002570 about?

NCT00002570 is a clinical study titled "Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which treatment regimen is more effective for colorectal cancer. PURPOSE: Randomized phase III trial to...

What is the current status of trial NCT00002570?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 67 participants. The study started on 1994-07-15. Estimated completion is 2009-02-10.

What interventions are being tested in trial NCT00002570?

The interventions under investigation include: fluorouracil (DRUG), leucovorin calcium (DRUG).

Who is sponsoring clinical trial NCT00002570?

This trial is sponsored by NCIC Clinical Trials Group, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.